Trademark Overview
On Thursday, August 19, 2021, a trademark application was filed for PROTEUS with the United States Patent and Trademark Office. The USPTO has given the PROTEUS trademark a serial number of 90891399. The federal status of this trademark filing is ABANDONED - EXPRESS as of Tuesday, November 22, 2022. This trademark is owned by Pythia Labs, Inc.. The PROTEUS trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Computer & Software Services & Scientific Services categories with the following description:
Downloadable software for research and development of pharmaceutical preparations, biomolecular therapeutics, and medicines; downloadable software for research and development of biomolecules; downloadable software for the design and discovery of pharmaceutical preparations, biomolecular therapeutics, and medicines; downloadable software for the design and discovery of biomolecules; downloadable software for data analysis, pattern discovery, contextual prediction, predictive analytics, and predictive modelling for use in research and development of biomolecules; downloadable artificial intelligence software for searching, tracking, exploration and analysis of data for use in the research and development of biomolecules; downloadable software in the fields of molecular biology for chemical and molecular analysis prediction, identification, development, and discovery of molecular structures, pharmaceuticals, and medicines
Design and development of customized artificial intelligence database software for others; research and development of software in the nature of a software module suite for the design and discovery of biomolecules; scientific and pharmaceutical artificial intelligence research services for others namely, development of artificial intelligence used to identify molecules and compounds for drug discovery and chemical development; software as a service (SAAS) services featuring software for research and development of pharmaceutical preparations, biomolecular therapeutics, and medicines; software as a services (SAAS) services featuring software for research and development of biomolecules; software as a services (SAAS) services featuring software for the design and discovery of pharmaceutical preparations, biomolecular therapeutics, and medicines; software as a service (SAAS) services featuring software for the design and discovery of biomolecules; software as a service (SAAS) services fea...